Pharmacogenomic Data Submissions: Guidance for Industry From Food and Drug Administration (FDA) πΊπΈ This document is a guidance for the industry on pharmacogenomic data submissions, covering administrative and procedural aspects and good clinical practice. Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are closed Temporal coverage filled Spatial coverage filled All files are available Learn more about this indicator Metadata quality: 66.66666666666666/100 Updated on April 27, 2020 Other (Public Domain) 0 reuses 0 favorites
Notice - Revision to Guidance Document: Submission of Pharmacogenomic Information From Health Canada π¨π¦ Provides guidance on how and when to submit pharmacogenomic information to Health Canada, in support of an application or submission for a drug, biologic drug, or medical device intended for human use, or as part of ongoing post-market activities Metadata quality: Metadata quality: Data description filled Files documentation missing License filled Update frequency not followed File formats are open Temporal coverage not set Spatial coverage filled All files are available Learn more about this indicator Metadata quality: 66.66666666666666/100 Updated on August 13, 2008 Open Government License 2.0 (Canada) 0 reuses 0 favorites
Consultations From Pharmaceuticals and Medical Devices Agency (PMDA) π―π΅ PMDA consultations. Metadata quality: Metadata quality: Data description empty Files documentation missing License filled Update frequency not followed File formats are open Temporal coverage not set Spatial coverage filled All files are available Learn more about this indicator Metadata quality: 55.55555555555556/100 Updated on May 30, 2024 Other (Public Domain) 0 reuses 0 favorites